IMU 0.00% 2.2¢ imugene limited

News: Imugene therapy targets cancer at Melbourne, Sydney Luncheons

  1. The “new” Imugene is involved in one of the hottest areas of cancer study and appears lightly valued V global peers in Immuno-Oncology...immunotherapy has become one of the most promising areas of study for the treatment of a variety of cancerous tumour. Charles Walker will present the new Imugene at the Melbourne (Tues 10th Feb) / Sydney Investor Luncheons (Wed 11th Feb).

watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Mkt cap $79.19M
Open High Low Value Volume
2.2¢ 2.3¢ 2.2¢ $43.89K 1.993M

Buyers (Bids)

No. Vol. Price($)
5 5725082 2.2¢

Sellers (Offers)

Price($) Vol. No.
2.3¢ 6438778 18
Last update - 12.04pm 22/10/2018 (20 minute delay) ?
0.00 ( 0.00 %)
Open High   Low Volume
2.2¢ 2.2¢   2.2¢ 1669412
Last updated 11.51am 22/10/2018 (live) ?
IMU (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.